$Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study$

Health-related quality of life in relapsed/refractory multiple myeloma treated with melflufen and dexamethasone: analyses from the phase III OCEAN study

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Haematologica (Roma) 2024-07, Vol.109 (7), p.2331-2336
Hauptverfasser:	Schjesvold, Fredrik H, Ludwig, Heinz, Delimpasi, Sossana, Robak, Pawel, Coriu, Daniel, Tomczak, Waldemar, Pour, Ludek, Spicka, Ivan, Dimopoulos, Meletios-Athanasios, Masszi, Tamas, Chernova, Natalia G, Sandberg, Anna, Thuresson, Marcus, Norin, Stefan, Bakker, Nicolaas A, Mateos, Maria-Victoria, Richardson, Paul G, Sonneveld, Pieter
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Combined Chemotherapy Protocols - adverse effects Antineoplastic Combined Chemotherapy Protocols - therapeutic use Dexamethasone - administration & dosage Dexamethasone - therapeutic use Drug Resistance, Neoplasm Female Humans Letter to the Editor Male Middle Aged Multiple Myeloma - drug therapy Neoplasm Recurrence, Local - drug therapy Phenylalanine - analogs & derivatives Phenylalanine - therapeutic use Quality of Life Recurrence Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:
ISSN:	0390-6078 1592-8721 1592-8721
DOI:	10.3324/haematol.2023.284635